GRNR Invest SRL
GRNR Invest reported total assets of €2.26m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
By total assets for 2025, GRNR Invest ranks among the 100 largest of the 327 companies in its sector (NACE 2110) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of GRNR Invest shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -81 % Total assets -62 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
GRNR Invest's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 27 Aug 2025
- Year ended 31 Dec 2023filed on 29 Jul 2024
- Year ended 31 Dec 2022filed on 03 Aug 2023
- Year ended 31 Dec 2021filed on 18 Oct 2022
GRNR Invest's financial analysis
- Solvency49.8%sector median: 56.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of GRNR Invest
GRNR Invest's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0817.694.459
- VAT number
- BE0817694459
- Peppol
- Registered · 0208:0817694459 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Jul 2009
- Registered office
- 1980 Zemst
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
GRNR Invest (SRL) has been based in Zemst since 2009, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net loss of 493,462 € and equity of €1.12m; its revenue is not published. Its solvency stands at 49.8%, below the median of its sector (56.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to GRNR Invest
Companies in the same business, of comparable size and area, outside its group.
- Pharma Chemicals France Manufacture of basic pharmaceutical products Braine-le-Château · balance sheet €1.08m
- XeroThera Europe Manufacture of basic pharmaceutical products Liège · balance sheet 820,359 €
- XpressBioX Manufacture of basic pharmaceutical products Herstal · balance sheet €8.92m
- Galenicap Manufacture of basic pharmaceutical products Ixelles · balance sheet €1.47m
- Rodilo Manufacture of pharmaceutical preparations Liège · balance sheet 204,587 €
- SpectronRx Europe Manufacture of basic pharmaceutical products Grimbergen · balance sheet 198,933 €
- Temmune Therapeutics Manufacture of pharmaceutical preparations Mechelen · balance sheet €3.43m
- S-Form Pharma Manufacture of basic pharmaceutical products Etterbeek · balance sheet 20,430 €
Frequently asked questions about GRNR Invest
What is the revenue of GRNR Invest?
GRNR Invest files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of GRNR Invest?
In Belgium, the VAT number is the company number prefixed with BE: BE0817694459 for GRNR Invest, if the company is VAT-registered. Its company number (CBE) is 0817.694.459.
Where is the registered office of GRNR Invest?
According to the CBE register, the registered office of GRNR Invest is in 1980 Zemst.
What is the equity of GRNR Invest?
At the close of the 2025 financial year, the equity of GRNR Invest amounts to 1,124,571 €, a solvency of 49.8% of total assets.
Who manages GRNR Invest?
The register lists 1 active mandates at GRNR Invest. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is GRNR Invest within its sector?
By total assets for 2025, GRNR Invest ranks among the 100 largest of the 327 companies in its sector (NACE 2110) in Belgium that filed accounts for that financial year.
The full file of GRNR Invest
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →